Episode 144: Monoclonal Antibodies to Treat Cancer and COVID-19
ONS member Donna Bydlon, BSN, RN, OCN®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing considerations for monoclonal antibodies to treat cancer and COVID-19 and how her institution responded to the pandemic. This episode is part of an ongoing series about outpatient oncology drug infusion. Other series' episodes are linked in the episode notes.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by February 26, 2023. The planners and faculty for this episode have no conflicts to disclose, and the episode has no commercial support. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Check out these resources from today’s episode:
- Complete this evaluation for free NCPD.
- Previous Oncology Nursing Podcast episodes on outpatient oncology drug infusion
- Oncology Nursing Forum article: Administration of Subcutaneous Monoclonal Antibodies in Patients With Cancer
- ONS/ASCO Chemotherapy Administration Safety Standards
- ONS/ONCC Chemotherapy Immunotherapy Certificate Course
- ONS Standard for Educating Nurses Who Administer Chemotherapy and Biotherapy
- National Cancer Institute’s dictionary of cancer terms
- U.S. Food and Drug Administration emergency use authorizations for COVID-19
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.